These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells. Laurencot CM; Kennedy KA Oncol Res; 1995; 7(7-8):371-9. PubMed ID: 8747600 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of intracellular chloride regulation induce cisplatin resistance in canine osteosarcoma cells. Yarbrough JW; Merryman JI; Barnhill MA; Hahn KA In Vivo; 1999; 13(5):375-83. PubMed ID: 10654189 [TBL] [Abstract][Full Text] [Related]
4. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo. Donnelly ET; Kelley M; Rockwell S Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460 [TBL] [Abstract][Full Text] [Related]
5. Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone. Newell KJ; Tannock IF Cancer Res; 1989 Aug; 49(16):4477-82. PubMed ID: 2743336 [TBL] [Abstract][Full Text] [Related]
6. pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Kennedy KA; McGurl JD; Leondaridis L; Alabaster O Cancer Res; 1985 Aug; 45(8):3541-7. PubMed ID: 3926302 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of compounds that interfere with the regulation of intracellular pH: a potential new class of anticancer drugs. Rotin D; Wan P; Grinstein S; Tannock I Cancer Res; 1987 Mar; 47(6):1497-504. PubMed ID: 3815351 [TBL] [Abstract][Full Text] [Related]
8. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns. Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331 [TBL] [Abstract][Full Text] [Related]
9. Initiation of motility by steelhead (Oncorhynchus mykiss) sperm: membrane ion exchangers and pH sensitivity. Ingermann RL; Holcomb M; Zuccarelli MD; Kanuga MK; Cloud JG Comp Biochem Physiol A Mol Integr Physiol; 2008 Dec; 151(4):651-6. PubMed ID: 18760373 [TBL] [Abstract][Full Text] [Related]
10. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition. González VM; Fuertes MA; Jiménez-Ruíz A; Alonso C; Pérez JM Mol Pharmacol; 1999 Apr; 55(4):770-7. PubMed ID: 10101036 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG). Kuin A; Aalders M; Lamfers M; van Zuidam DJ; Essers M; Beijnen JH; Smets LA Br J Cancer; 1999 Feb; 79(5-6):793-801. PubMed ID: 10070871 [TBL] [Abstract][Full Text] [Related]
12. The change of intracellular pH is involved in the cisplatin-resistance of human lung adenocarcinoma A549/DDP cells. Huang Z; Huang Y Cancer Invest; 2005; 23(1):26-32. PubMed ID: 15779865 [TBL] [Abstract][Full Text] [Related]
13. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Keyes SR; Rockwell S; Sartorelli AC Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504 [TBL] [Abstract][Full Text] [Related]
14. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile]. Hu S; Hu CP; Liang CH Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030 [TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218 [TBL] [Abstract][Full Text] [Related]
16. Cell shrinkage evoked by Ca2+-free solution in rat alveolar type II cells: Ca2+ regulation of Na+-H+ exchange. Murao H; Shimizu A; Hosoi K; Iwagaki A; Min KY; Kishima G; Hanafusa T; Kubota T; Kato M; Yoshida H; Nakahari T Exp Physiol; 2005 Mar; 90(2):203-13. PubMed ID: 15640277 [TBL] [Abstract][Full Text] [Related]
17. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031 [TBL] [Abstract][Full Text] [Related]
18. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY; Rogers PM; Kelland LR Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070 [TBL] [Abstract][Full Text] [Related]
19. Control of hepatocyte DNA synthesis by intracellular pH and its role in the action of tumor promoters. Lee CH; Cragoe EJ; Edwards AM J Cell Physiol; 2003 Apr; 195(1):61-9. PubMed ID: 12599209 [TBL] [Abstract][Full Text] [Related]
20. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells. Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]